Clinical Trial for Advanced Bile Duct Cancer
0 Views
administrator
07/01/23
Learn about a phase II multi-center study evaluating combination immunotherapy for advanced cholangiocarcinoma (bile duct cancer) with pembrolizumab and Sylatron (peginterferon alfa-2b): HCRN GI16-263. https://hoosiercancer.org/clin....ical-trials/trial/gi
Show more
Facebook Comments
No comments found